Based on the historical similar news and price impact, the current week's news sentiment for Dr. Reddy's Laboratories is NEUTRAL.

The appointment of Milan Kalawadia as CEO North America is a notable event, but the historical data suggests that the market reaction to such news is not significantly positive or negative. The impact of similar news in the past has been mostly negative, with a average impact of around -3.07%. However, the news itself is a neutral event, and the market reaction may depend on other factors such as the company's performance, industry trends, and overall market conditions.

Therefore, the news tone is neutral, and investors should consider other factors before making a decision on the stock.